AM-101 in the Treatment of Post-Acute Tinnitus 1

Summary

The purpose of this research study is to test the safety and local tolerance of repeated treatment cycles of AM-101.

Timeline

Start

2014-06

Primary completion

2017-01

Completion

2017-01

Outcome

Missed primary endpoint

registry analysis (superiority test); 1 Cycle AM-101 vs 2 Cycles AM-101; p = 0.128; Fisher Exact NCT01934010 ↗

registry analysis (superiority test); 2 Cycles AM-101 vs 3 Cycles AM-101; p = 0.4403; Fisher Exact NCT01934010 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Esketamine	Other / unclassified	—	Other

Indications